Smith Group Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,450
| Closed | -$91K | – | 341 |
|
|
2020
Q2 | $91K | Sell |
1,450
-20
| -1% | -$1.26K | 0.01% | 197 |
|
|
2020
Q1 | $62K | Hold |
1,470
| – | – | ﹤0.01% | 236 |
|
|
2019
Q4 | $67K | Hold |
1,470
| – | – | ﹤0.01% | 263 |
|
|
2019
Q3 | $67K | Buy |
1,470
+300
| +26% | +$13.7K | ﹤0.01% | 261 |
|
|
2019
Q2 | $69K | Hold |
1,170
| – | – | ﹤0.01% | 258 |
|
|
2019
Q1 | $52K | Sell |
1,170
-4,200
| -78% | -$187K | ﹤0.01% | 298 |
|
|
2018
Q4 | $209K | Sell |
5,370
-200
| -4% | -$7.78K | 0.01% | 241 |
|
|
2018
Q3 | $256K | Sell |
5,570
-110
| -2% | -$5.06K | 0.01% | 237 |
|
|
2018
Q2 | $248K | Buy |
+5,680
| New | +$248K | 0.01% | 236 |
|
|
2013
Q3 | – | Sell |
-7,667
| Closed | -$590K | – | 450 |
|
|
2013
Q2 | $590K | Buy |
+7,667
| New | +$590K | 0.03% | 204 |
|